Chong Kun Dang Pharmaceutical (185750) — Financial Flexibility Index
Chong Kun Dang Pharmaceutical (185750) has a Financial Flexibility Index of 0.22x as of September 2025. Free cash flow of ₩125.59 Billion (operating CF ₩21.45 Billion minus capex ₩104.14 Billion) represents 0% of total liabilities (₩576.36 Billion). Also explore Chong Kun Dang Pharmaceutical equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chong Kun Dang Pharmaceutical Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Chong Kun Dang Pharmaceutical across 9 annual periods. Check asset allocation strategy of Chong Kun Dang Pharmaceutical to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Chong Kun Dang Pharmaceutical (2016–2024)
Year-by-year free cash flow to debt coverage for Chong Kun Dang Pharmaceutical. For the full company profile including market capitalisation, see 185750 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | ₩130.39 Billion | ₩64.29 Billion | ₩562.39 Billion | ▼ -64.8% |
| 2023 | 0.66x | ₩386.97 Billion | ₩318.16 Billion | ₩586.79 Billion | ▲ +194.9% |
| 2022 | 0.22x | ₩112.63 Billion | ₩67.73 Billion | ₩503.59 Billion | ▲ +75.9% |
| 2021 | 0.13x | ₩61.15 Billion | ₩12.90 Billion | ₩480.89 Billion | ▼ -63.4% |
| 2020 | 0.35x | ₩136.96 Billion | ₩104.32 Billion | ₩394.74 Billion | ▲ +14.2% |
| 2019 | 0.30x | ₩99.13 Billion | ₩77.29 Billion | ₩326.40 Billion | ▲ +32.0% |
| 2018 | 0.23x | ₩64.54 Billion | ₩42.63 Billion | ₩280.60 Billion | ▼ -37.9% |
| 2017 | 0.37x | ₩101.46 Billion | ₩81.67 Billion | ₩273.91 Billion | ▲ +9.5% |
| 2016 | 0.34x | ₩97.23 Billion | ₩57.79 Billion | ₩287.45 Billion | — |